Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7565020 in healthy volunteers and individuals with chronic hepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• RO7565020 (RO7565020)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Hepatitis B | Phase 1 | Status: TERMINATED | Results posted: 2026-01-22